Stay updated on XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial
Sign up to get notified when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.

Latest updates to the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s platform/release version tag is updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This represents a minor site maintenance/version update rather than a change to the clinical trial study details.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check55 days agoChange DetectedNew study sites have been added, including Hospital Clínico San Carlos (Madrid), Neurosphera (Warsaw), Prince of Wales Hospital (Randwick), Royal Prince Alfred Hospital (Camperdown), and Austin Epilepsy Care Center (Austin). The total number of locations is updated to 94.SummaryDifference0.6%

- Check83 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check90 days agoChange DetectedNew recruitment sites have been added (Royal Melbourne Hospital in Melbourne, Australia; Hospital Central Ramon Carrilo in San Luis, Argentina; Clinical Trials, Inc. in Little Rock, Arkansas), increasing the total number of locations from 86 to 89.SummaryDifference0.5%

Stay in the know with updates to XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.